Neonatal rotavirus vaccination making headway

Affiliations

Comment

Timo Vesikari. Lancet Infect Dis. 2015 Dec.

. 2015 Dec;15(12):1362-3.

doi: 10.1016/S1473-3099(15)00295-9. Epub 2015 Aug 26.

¹ Vaccine Research Center, University of Tampere, Biokatu 10, 33014 Tampere, Finland. Electronic address: timo.vesikari@uta.fi.

No abstract available

Comment on

Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trial.
Bines JE, Danchin M, Jackson P, Handley A, Watts E, Lee KJ, West A, Cowley D, Chen MY, Barnes GL, Justice F, Buttery JP, Carlin JB, Bishop RF, Taylor B, Kirkwood CD; RV3 Rotavirus Vaccine Program. Bines JE, et al. Lancet Infect Dis. 2015 Dec;15(12):1389-97. doi: 10.1016/S1473-3099(15)00227-3. Epub 2015 Aug 26. Lancet Infect Dis. 2015. PMID: 26318715 Clinical Trial.